Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.48 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12622046 | 0.97 | GLA (0.60) | GLAL3MBTL1ALDH1A1LMNAHCRTR1 | |
| SCHEMBL12621830 | 0.92 | ALDH1A1 (0.59) | L3MBTL1ALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL15423988 | 0.90 | GLA (0.52) | GLAL3MBTL1ALDH1A1LMNAHCRTR1 | |
| SCHEMBL12621865 | 0.89 | L3MBTL1 (0.68) | L3MBTL1ALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL12622095 | 0.89 | L3MBTL1 (0.68) | L3MBTL1ALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL12624085 | 0.85 | ALDH1A1 (0.57) | L3MBTL1ALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL20362792 | 0.85 | ALDH1A1 (0.51) | L3MBTL1ALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL12622090 | 0.84 | ALDH1A1 (0.49) | L3MBTL1ALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL12624082 | 0.84 | ALDH1A1 (0.56) | L3MBTL1ALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL12626263 | 0.84 | ALDH1A1 (0.50) | L3MBTL1ALDH1A1NPC1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8580808-B2 | Filamin A-binding anti-inflammatory analgesic | Pain Therapeutic, Inc. (US) | 2013-11-12 | — | — | US | disclosed |
| US-8580809-B2 | Filamin A-binding anti-inflammatory analgesic | PAIN THERAPEUTICS, INC. (US) | 2013-11-12 | — | — | US | disclosed |
| US-20110105484-A1 | FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC | PAIN THERAPEUTICS | 2011-05-05 | — | — | US | disclosed |
| US-20110105547-A1 | FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC | PAIN THERAPEUTICS | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105484-A1 | FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC | FLNA, FLNB, OPRK1 | GLA 1466/4885L3MBTL1 3970/4885ALDH1A1 2702/4885 |
| US-20110105547-A1 | FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC | FLNA, FLNB, OPRK1 | GLA 1466/4885L3MBTL1 3970/4885ALDH1A1 2702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.